ArticleBiomolecules2026

Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study.

Jiajun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.